TMPRSS7
Transmembrane protease serine 7
Also known as: TMPS7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTY8
- Gene
- TMPRSS7
- Ensembl
- ENSG00000176040
- Chromosome
- 3
- Canonical length
- 843 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable serine-type peptidase activity. Predicted to be involved in proteolysis. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
843 residues, UniProt reviewed canonical sequence.
>Q7RTY8|TMPRSS7
1 MDKENSDVSA APADLKISNI SVQVVSAQKK LPVRRPPLPG RRLPLPGRRP PQRPIGKAKP
61 KKQSKKKVPF WNVQNKIILF TVFLFILAVI AWTLLWLYIS KTESKDAFYF AGMFRITNIE
121 FLPEYRQKES REFLSVSRTV QQVINLVYTT SAFSKFYEQS VVADVSSNNK GGLLVHFWIV
181 FVMPRAKGHI FCEDCVAAIL KDSIQTSIIN RTSVGSLQGL AVDMDSVVLN AGLRSDYSST
241 IGSDKGCSQY FYAEHLSLHY PLEISAASGR LMCHFKLVAI VGYLIRLSIK SIQIEADNCV
301 TDSLTIYDSL LPIRSSILYR ICEPTRTLMS FVSTNNLMLV TFKSPHIRRL SGIRAYFEVI
361 PEQKCENTVL VKDITGFEGK ISSPYYPSYY PPKCKCTWKF QTSLSTLGIA LKFYNYSITK
421 KSMKGCEHGW WEINEHMYCG SYMDHQTIFR VPSPLVHIQL QCSSRLSDKP LLAEYGSYNI
481 SQPCPVGSFR CSSGLCVPQA QRCDGVNDCF DESDELFCVS PQPACNTSSF RQHGPLICDG
541 FRDCENGRDE QNCTQSIPCN NRTFKCGNDI CFRKQNAKCD GTVDCPDGSD EEGCTCSRSS
601 SALHRIIGGT DTLEGGWPWQ VSLHFVGSAY CGASVISREW LLSAAHCFHG NRLSDPTPWT
661 AHLGMYVQGN AKFVSPVRRI VVHEYYNSQT FDYDIALLQL SIAWPETLKQ LIQPICIPPT
721 GQRVRSGEKC WVTGWGRRHE ADNKGSLVLQ QAEVELIDQT LCVSTYGIIT SRMLCAGIMS
781 GKRDACKGDS GGPLSCRRKS DGKWILTGIV SWGHGSGRPN FPGVYTRVSN FVPWIHKYVP
841 SLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMPRSS7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 1.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 1.3 nTPM
- fallopian tube: 0.3 nTPM
- choroid plexus: 0.2 nTPM
- small intestine: 0.2 nTPM
- stomach: 0.2 nTPM
- thymus: 0.2 nTPM
Single-cell type
- late primary spermatocytes: 18 nCPM
- respiratory ciliated cells: 14 nCPM
- goblet cells: 8.3 nCPM
- corticotrophs: 7.6 nCPM
- fallopian tube ciliated cells: 6.4 nCPM
- early spermatids: 6.2 nCPM
Immune cell
- basophil: 0.5 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
Brain region
- choroid plexus: 1 nTPM
- cerebellum: 0.9 nTPM
- cerebral cortex: 0.7 nTPM
- basal ganglia: 0.6 nTPM
- spinal cord: 0.6 nTPM
- white matter: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SEA domain
- CUB domain
- Serine proteases, trypsin domain
- Peptidase S1A, chymotrypsin family
- Low-density lipoprotein (LDL) receptor class A repeat
- Peptidase S1, PA clan
- Serine proteases, trypsin family, histidine active site
- Low-density lipoprotein (LDL) receptor class A, conserved site
- Serine proteases, trypsin family, serine active site
- Spermadhesin, CUB domain superfamily
- LDL receptor-like superfamily
- SEA domain superfamily
- Low-density lipoprotein receptor domain class A
- Trypsin
- CUB domain
- SEA domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMPRSS7 as an antibody target. Whether an autoantibody or antibody against TMPRSS7 could matter depends on whether native TMPRSS7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMPRSS7 is annotated at the cell surface, where native TMPRSS7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMPRSS7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...